Incidence of herpes zoster in patients with giant cell arteritis: A population-based cohort study

Rheumatology

Volumn 49, Issue 11, 2010, Pages 2104-2108

  Schäfer, Valentin S ^a   Kermani, Tanaz A ^a   Crowson, Cynthia S ^a   Hunder, Gene G ^a   Gabriel, Sherine E ^a   Ytterberg, Steven R ^a   Matteson, Eric L ^a   Warrington, Kenneth J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Giant cell arteritis; Glucocorticoids; Herpes zoster

Indexed keywords

GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GIANT CELL ARTERITIS; HAZARD RATIO; HERPES ZOSTER; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; POPULATION; POPULATION BASED CASE CONTROL STUDY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GIANT CELL ARTERITIS; GLUCOCORTICOIDS; HERPES ZOSTER; HUMANS; MALE; POPULATION SURVEILLANCE; RISK FACTORS; STATISTICS AS TOPIC;

EID: 78649336730     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq200     Document Type: Article

References (20)

1. Abendroth A, Arvin AM. Immune evasion as a pathogenic mechanism of varicella zoster virus. Semin Immunol 2001;13:27-39.
2. Strangfeld A, Listing J, Herzer P et al. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA 2009;301:737-44.
3. Smitten AL, Choi HK, Hochberg MC et al. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum 2007;57:1431-8.
4. Pope JE, Krizova A, Ouimet JM, Goodwin JL, Lankin M. Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or non-inflammatory musculoskeletal disorders. J Rheumatol 2004;31:274-9.
5. Nagasawa K, Yamauchi Y, Tada Y, Kusaba T, Niho Y, Yoshikawa H. High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann Rheum Dis 1990;49:630-3.
6. McDonald JR, Zeringue AL, Caplan L et al. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis 2009;48:1364-71.
7. Kahl LE. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome. J Rheumatol 1994;21:84-6.
8. Chakravarty EF. Viral infection and reactivation in autoimmune disease. Arthritis Rheum 2008;58:2949-57.
9. Wolfe F, Michaud K, Chakravarty EF. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders. Rheumatology 2006;45:1370-5.
10. Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 2004;51:264-8.
11. Kermani TA, Schafer VS, Crowson CS et al. Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis 2009;69:780-1.
12. Maradit Kremers H, Crowson CS, Gabriel SE. Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases. Rheum Dis Clin North Am 2004;30:819-34.
13. Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
14. Cox D. Some simple approximate tests for Poisson variates. Biometrika 1953;40:354.
15. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007;82:1341-9.
16. Charlier C, Henegar C, Launay O et al. Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients. Ann Rheum Dis 2009;68:658-63.
17. Wung PK, Holbrook JT, Hoffman GS et al. Herpes zoster in immunocompromised patients: incidence, timing, and risk factors. Am J Med 2005;118:1416.
18. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 2004;4:26-33.
19. Proven A, Gabriel SE, Orces C, O'Fallon WM, Hunder GG. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 2003;49:703-8.
20. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003;48:3522-31.